Markets › United States › NAS › CODX

Co-Diagnostics Inc

NAS:CODXHealthcarenasdaq_composite

$0.6660+1.83%At closeAt close · Tue 20 Oct · ≈ AED 2.45 · Market cap $4.96M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	77.7%	88.2%	84.0%	38.6%	74.5%	64.3%	—	—
Operating margin	55.9%	47.1%	−78.8%	−626.9%	−1,023.7%	−5,025.5%	−5,025.5%	+0.0 pts
Net margin	57.0%	37.5%	−41.6%	−518.7%	−961.4%	−7,533.6%	−7,533.6%	+0.0 pts
EBITDA margin	56.1%	47.0%	−30.1%	−541.4%	−924.7%	−7,615.4%	—	—
Return on equity	63.7%	27.3%	−12.4%	−41.1%	−69.3%	−227.3%	−227.3%	+0.0 pts
Return on assets	59.6%	22.9%	−11.6%	−37.1%	−58.8%	−189.5%	−189.5%	+0.0 pts
Return on capital employed	62.1%	31.2%	−22.6%	−47.7%	−70.7%	−147.5%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.1×	0.1×	+0.0%
Debt / assets	0.0%	0.0%	0.3%	3.1%	3.4%	5.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	16.8×	9.1×	23.9×	10.8×	4.4×	3.9×	3.9×	+0.0%
Quick ratio	14.9×	9.0×	22.6×	10.5×	4.3×	3.6×	—	—
Cash ratio	10.6×	7.0×	5.9×	2.6×	0.4×	3.4×	3.4×	+0.0%
Asset turnover	1.0×	0.6×	0.3×	0.1×	0.1×	0.0×	—	—
Inventory turnover	2.1×	5.8×	1.0×	2.5×	0.9×	0.2×	—	—
Receivables turnover	6.1×	4.7×	6.3×	20.6×	29.5×	3.3×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—